NEW RESEARCH PAPER SUPPORTS USING MICROBIOME DATA TO DEVELOP POTENTIAL PROBIOTIC THERAPIES
CLEVELAND, Jan. 26, 2023 /PRNewswire/ -- In a new paper, published Jan. 25, 2023, online by the journal Gastroenterology, researchers from University Hospitals (UH) Cleveland Medical Center and Case Western Reserve University School of Medicine, review studies about the microbiome's role in disease and health, and discuss tactics for developing probiotics to modulate the microbiome through leveraging microbiome data. They illustrate these tactics by using Crohn's disease (CD) as an example.
- The comprehensive intestinal microbiome, representing bacterial and fungal communities, profiles were assessed at the start of the study and following four weeks of probiotic consumption.
- Through the analysis of big microbiome data sets, researchers have started to appreciate the microbiome composition differences between different cohorts of individuals.
- That has lead to the opportunity to leverage such data insights for targeted microbiome solution development.
- The probiotic formulation developed through this data-powered design process was launched in market by BIOHM Health Inc. as a general wellness probiotic.